| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| William Y Oyadomari, Thays C Santiago, Leonardo Basso, Vitor Oliveira, Fábio C Cruz, João V Nani, Mirian A F Hayash. Long-term treatment with haloperidol modulates angiotensin I-converting enzyme (ACE) activity in transgenic animal model with construct validity for schizophrenia studies. Brain research. 2025-04-14. PMID:40228572. |
long-term treatment with haloperidol modulates angiotensin i-converting enzyme (ace) activity in transgenic animal model with construct validity for schizophrenia studies. |
2025-04-14 |
2025-04-17 |
human |
| Madeline Chidiac, Bushra Elhusein, Niman Gajebasi. Reassessing mirtazapine and akathisia: A case report on its efficacy in treating severe, treatment-resistant akathisia and a review of the evidence. SAGE open medical case reports. vol 12. 2024-12-02. PMID:39618703. |
this report discusses a 44-year-old man with a diagnosis of schizophrenia who developed severe, treatment-resistant akathisia after taking haloperidol, a first-generation antipsychotic. |
2024-12-02 |
2024-12-06 |
Not clear |
| B R Pradeepa, T M Vijayakumar, K Manikanda. Effects of piperine-haloperidol mixture on ketamine induced schizophrenia rats and metabolism-mediated inhibitory potency: in-vivo and in-vitro evaluation. 3 Biotech. vol 14. issue 12. 2024-12-02. PMID:39619819. |
haloperidol, a conventional antipsychotic, was mixed with piperine in a ketamine-induced schizophrenia rat model to evaluate the interaction potential of this mixture through in-vitro and in-vivo analyses. |
2024-12-02 |
2024-12-06 |
human |
| Tatiana V Lipina, Huy Giang, Jonathan S Thacker, William C Wetsel, Marc G Caron, Jean Martin Beaulieu, Ali Salahpour, Amy J Ramse. Combination of haloperidol with UNC9994, β-arrestin-biased analog of aripiprazole, ameliorates schizophrenia-related phenotypes induced by NMDAR deficit in mice. The international journal of neuropsychopharmacology. 2024-11-29. PMID:39612588. |
aripiprazole, an atypical antipsychotic drug (apd), acts as a dopamine partial agonist and its combination with haloperidol (a typical apd) was suggested as a potential strategy to improve schizophrenia. |
2024-11-29 |
2024-12-02 |
mouse |
| Tatiana V Lipina, Huy Giang, Jonathan S Thacker, William C Wetsel, Marc G Caron, Jean Martin Beaulieu, Ali Salahpour, Amy J Ramse. Combination of haloperidol with UNC9994, β-arrestin-biased analog of aripiprazole, ameliorates schizophrenia-related phenotypes induced by NMDAR deficit in mice. The international journal of neuropsychopharmacology. 2024-11-29. PMID:39612588. |
hence, one of our objectives was to probe the behavioral effects of co-administrating haloperidol with unc9994 in nmdar mouse models of schizophrenia. |
2024-11-29 |
2024-12-02 |
mouse |
| Yong Soo Park, Gyu Min Kim, Ho Jun Sung, Ju Yeong Yu, Ki-Wug Sun. Haloperidol, a typical antipsychotic, inhibits 5-HT The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology. 2024-11-21. PMID:39572369. |
haloperidol, a typical antipsychotic, inhibits 5-ht haloperidol is a typical antipsychotic drug effective in alleviating positive symptoms of schizophrenia by blocking dopamine receptor 2 (dr2). |
2024-11-21 |
2024-11-24 |
Not clear |
| Rihab Farooq, Huda Zahid, Ammara Shakil Sahibole, Syed Ali Bokhari, Mazin A Mukhta. Complex Pharmacodynamics of Aripiprazole and Haloperidol in Schizophrenia Management: A Case Report. Cureus. vol 16. issue 10. 2024-11-14. PMID:39525142. |
complex pharmacodynamics of aripiprazole and haloperidol in schizophrenia management: a case report. |
2024-11-14 |
2024-11-17 |
Not clear |
| Rihab Farooq, Huda Zahid, Ammara Shakil Sahibole, Syed Ali Bokhari, Mazin A Mukhta. Complex Pharmacodynamics of Aripiprazole and Haloperidol in Schizophrenia Management: A Case Report. Cureus. vol 16. issue 10. 2024-11-14. PMID:39525142. |
this case report discusses a 44-year-old male with chronic schizophrenia who experienced worsening psychotic symptoms following an interaction between aripiprazole, a partial dopamine agonist, and haloperidol, a first-generation antipsychotic (fga). |
2024-11-14 |
2024-11-17 |
Not clear |
| Pallavi Abhilasha, Neena Bhatti, Girish Joseph, Ranjit J Injet. Clozapine-induced acute akathisia: A case report. Journal of family medicine and primary care. vol 13. issue 9. 2024-10-28. PMID:39464978. |
a 34-year-old woman with a 7-year history of schizophrenia exhibited positive and negative symptoms, initially treated with haloperidol and clonazepam. |
2024-10-28 |
2024-10-30 |
Not clear |
| Maxens Decavèle, Jérémie Pichon, Anne Fajac, Audrey Milon, Martine Antoine, Aude Gibelin, Antoine Parrot, Muriel Fartouk. Case 327: Exogenous Lipoid Pneumonia. Radiology. vol 312. issue 1. 2024-07-30. PMID:39078300. |
the patient had obesity (body mass index, 36), stage 3 vascular chronic renal insufficiency, and hebephrenic schizophrenia treated with haloperidol, carbamazepine, and cyamemazine. |
2024-07-30 |
2024-08-02 |
Not clear |
| Khasan Ibragimov, Gregory Peter Keane, Cristina Carreño Glaría, Jie Cheng, Augusto Eduardo Llos. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders. The Cochrane database of systematic reviews. vol 7. 2024-07-03. PMID:38958149. |
haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders. |
2024-07-03 |
2024-07-06 |
Not clear |
| Andreea O Diaconescu, Povilas Karvelis, Daniel J Hauk. Rethinking interpersonal judgments: dopamine antagonists impact attributional dynamics. Trends in cognitive sciences. 2024-05-26. PMID:38797602. |
using computational modeling, they demonstrate that haloperidol increases belief flexibility, reducing paranoia-like interpretations by enhancing sensitivity to social context and reducing self-relevant perspective taking, offering a mechanistic explanation for its therapeutic potential in schizophrenia. |
2024-05-26 |
2024-05-31 |
Not clear |
| Mingwei Gao, Fuqi Wang, Chuanyao Sun, Shuzhuo Zhang, Ruibin S. Effects of olanzapine on hippocampal CA3 and the prefrontal cortex local field potentials. European journal of pharmacology. 2024-02-07. PMID:38325793. |
olanzapine is an antipsychotic drug applied in psychiatry to treat psychoses, especially schizophrenia and schizoaffective disorders with similar or better improvement than haloperidol and risperidone in the treatment of depressive and negative symptoms. |
2024-02-07 |
2024-02-10 |
Not clear |
| Jie Zhong, Yuan Jia, Hong Zhu, Dan Wang, Hongxiao Ji. Effects of Ziprasidone or Haloperidol on Theory of Mind in Patients With Schizophrenia: A 16-week Pilot Trial. Journal of psychiatric practice. vol 30. issue 1. 2024-01-16. PMID:38227725. |
effects of ziprasidone or haloperidol on theory of mind in patients with schizophrenia: a 16-week pilot trial. |
2024-01-16 |
2024-01-19 |
Not clear |
| Shutaro Sugita, Hiroi Tomioka, Kensuke Mera, Taro Tazaki, Hana Nishiyama, Hiroki Yamada, Kenji Sanada, Atsuko Inamoto, Akira Iwanam. Neutrophil-Lymphocyte Ratio in Patients With Acute Schizophrenia. Cureus. vol 16. issue 1. 2024-01-15. PMID:38222994. |
methods we retrospectively examined 251 inpatients diagnosed with schizophrenia and classified them according to treatment (intravenous haloperidol vs. oral antipsychotic medication during the acute phase) and investigated their nlr and nar while receiving inpatient care. |
2024-01-15 |
2024-01-17 |
Not clear |
| Gabriela Xavier Santos, Joyce Elise Dos SantosTeodoro, Mylena Gonçalves Fonseca, Renata Moreira Acunha, Pedro Ismael da Silva Júnior, Luciana Maria Dos Reis, Renato Leonardo de Freitas, Priscila Medeiro. Mygalin, an Acanthoscurria gomesiana spider-derived synthetic, modulates haloperidol-induced cataleptic state in mice. Neuroscience letters. 2023-12-10. PMID:38072029. |
haloperidol (hal) is an antipsychotic used in the treatment of schizophrenia. |
2023-12-10 |
2023-12-17 |
mouse |
| S Echater, B Onei. Improvement of Tardive Dyskinesias with Olanzapine. Case reports in psychiatry. vol 2023. 2023-11-01. PMID:37908858. |
in this article, we present the case of a 29-year-old man with schizophrenia who developed td following treatment with haloperidol. |
2023-11-01 |
2023-11-08 |
Not clear |
| Manuel Menendez, Temilola Majekodunmi, Farah Chohan, Aaron Perez-Castaneda, Hiram Maldonado Rivera, Eugenio Angueira-Serrano, George Miche. A Rare Case of Myxedema Coma Precipitated by a Single Dose of Haloperidol in a Patient With Paranoid Schizophrenia. Cureus. vol 15. issue 9. 2023-10-16. PMID:37842468. |
a rare case of myxedema coma precipitated by a single dose of haloperidol in a patient with paranoid schizophrenia. |
2023-10-16 |
2023-11-08 |
Not clear |
| Chang Hyeon Kong, Kyungnam Cho, Ji Won Min, Jae Youn Kim, Keontae Park, Do Yeon Kim, Mijin Jeon, Woo Chang Kang, Seo Yun Jung, Jae Yeol Lee, Jong Hoon Ry. Oleanolic acid alleviates the extrapyramidal symptoms and cognitive impairment induced by haloperidol through the striatal PKA signaling pathway in mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 168. 2023-10-09. PMID:37812895. |
haloperidol, one of the representative typical antipsychotics, is on the market for schizophrenia but shows severe adverse effects such as extrapyramidal symptoms (eps) or cognitive impairments. |
2023-10-09 |
2023-10-15 |
mouse |
| Cátia Santa, Diana Rodrigues, Joana F Coelho, Sandra I Anjo, Vera M Mendes, Diogo Bessa-Neto, Michael J Dunn, David Cotter, Graça Baltazar, Patrícia Monteiro, Bruno Manada. Chronic treatment with D2-antagonist haloperidol leads to inhibitory/excitatory imbalance in striatal D1-neurons. Translational psychiatry. vol 13. issue 1. 2023-10-06. PMID:37803004. |
haloperidol is a typical antipsychotic medication used in the treatment of schizophrenia that is known to antagonize dopamine d2 receptors, which are abundantly expressed in the striatum. |
2023-10-06 |
2023-10-15 |
mouse |